Epithelial-mesenchymal transition in prostate cancer and the potential role of kallikrein serine proteases (Q36857803)

16 August 2017

1 reference

title

Epithelial-mesenchymal transition in prostate cancer and the potential role of kallikrein serine proteases (English)

1 reference

16 August 2017

1 reference

Astrid K Whitbread

3

0 references

Mitchell G Lawrence

object named as

Mitchell G Lawrence

1

0 references

Judith Clements

object named as

Judith A Clements

5

0 references

author name string

Tara L Veveris-Lowe

2

1 reference

PubMed ID

17587816

16 August 2017

David L Nicol

4

1 reference

16 August 2017

1 January 2007

1 reference

16 August 2017

1 reference

16 August 2017

185

1 reference

16 August 2017

1-3

1 reference

16 August 2017

111-115

1 reference

A direct beta-catenin-independent interaction between androgen receptor and T cell factor 4

16 August 2017

1 reference

TGF beta in prostate cancer: a growth inhibitor that can enhance tumorigenicity

21 January 2018

1 reference

TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia

21 January 2018

1 reference

EGF receptor (EGFR) signaling promoting invasion is disrupted in androgen-sensitive prostate cancer cells by an interaction between EGFR and androgen receptor (AR).

21 January 2018

1 reference

Induction by transforming growth factor-beta1 of epithelial to mesenchymal transition is a rare event in vitro

21 January 2018

1 reference

E-cadherin and beta-catenin are down-regulated in prostatic bone metastases.

21 January 2018

1 reference

Dual roles of E-cadherin in prostate cancer invasion

21 January 2018

1 reference

The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers

21 January 2018

1 reference

Preferential production of latent transforming growth factor beta-2 by primary prostatic epithelial cells and its activation by prostate-specific antigen

21 January 2018

1 reference

Functions and regulation of transforming growth factor-beta (TGF-beta) in the prostate

21 January 2018

1 reference

Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancer

21 January 2018

1 reference

Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence

21 January 2018

1 reference

Lower levels of nuclear beta-catenin predict for a poorer prognosis in localized prostate cancer.

21 January 2018

1 reference

Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer

21 January 2018

1 reference

Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion.

21 January 2018

1 reference

Akt-regulated pathways in prostate cancer

21 January 2018

1 reference

Substrates of the prostate-specific serine protease prostase/KLK4 defined by positional-scanning peptide libraries

21 January 2018

1 reference

Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies

21 January 2018

1 reference

Potential action of IGF-1 and EGF on androgen receptor nuclear transfer and transactivation in normal and cancer human prostate cell lines

21 January 2018

1 reference

Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability

21 January 2018

1 reference

E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology.

21 January 2018

1 reference

Testosterone and prostate specific antigen stimulate generation of reactive oxygen species in prostate cancer cells

21 January 2018

1 reference

The fallacy of epithelial mesenchymal transition in neoplasia

21 January 2018

1 reference

Epithelial-mesenchymal transitions in development and pathologies

21 January 2018

1 reference

Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition?

21 January 2018

1 reference

TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition

21 January 2018

1 reference

Roles and regulation of Wnt signaling and beta-catenin in prostate cancer

21 January 2018

1 reference

Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells

21 January 2018

1 reference

Diverse biological effect and Smad signaling of bone morphogenetic protein 7 in prostate tumor cells

21 January 2018

1 reference

Wnt, hedgehog and snail: sister pathways that control by GSK-3beta and beta-Trcp in the regulation of metastasis

21 January 2018

1 reference

Abnormal E-cadherin expression and prostate cell blood dissemination as markers of biological recurrence in cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000101311

1 reference

16 August 2017

1 reference

PubMed ID

17587816